Nav: Home

Genetic variation is key to fighting viruses

October 08, 2015

Using a genome-wide association study, EPFL scientists have identified subtle genetic changes that can cause substantial differences to how we fight viral infections.

When infected with a virus, the response of our immune systems varies widely from person to person. This variation is of great concern, as these differences can determine clinical outcome as well as effectiveness of vaccinations. Comparing the genomes of over 2000 people, scientists from EPFL and the Max Plank Institute have pinpointed a genetic link behind immune variations. Published in the American Journal of Human Genetics, the work connects genetics to antiviral immunity while offering a new path for studying this relationship in other medical contexts.

Studying genomes to spot correlations

The mapping of the human genome - the complete set of DNA of a single person - in 2001 opened up an immensely complex network of genetic information. Biologists today have tools that can study whole genomes instead of individual genes, which has proven very useful when trying to identify which gene or genes are behind complex biological functions, such as immunity.

One of these tools is called a "genome-wide association study". In these studies, computers are used to rapidly scan the genomes of many people to find patterns of genetic variations associated with a particular biological function or a disease.

Genomes, viruses and the immune system

The lab of Jacques Fellay at EPFL performed a genome-wide association study on over 2000 people to uncover the genetic elements that underlie the immune response to viruses. The study, led by postdoc Christian Hammer, looked at fourteen common viruses against which antibodies are developed following natural infection or vaccination. Each one of the people tested had developed varying degrees of immunity against each virus, which can be assessed by measuring the presence and concentration of a particular antibody in their blood.

Using this information, the EPFL scientists also looked at the genetic data from each patient to identify correlations of about 6 million common variants across the whole genome with the degree of immune response to each virus. This complex analysis generated masses of digital data, which had to be processed in specialized computer systems at the Vital-IT Group facilities in Lausanne.

Of the fourteen viruses, the study found "hits" on four: influenza A virus, Epstein-Barr virus, JC polyomavirus, and Merkel cell polyomavirus. There seemed to be a strong connection between immune responses to these and genetic variations across a cluster of genes that are known to be involved with the immune response to viruses.

Specifically, these genes - all located on the same chromosome - produce a group of proteins whose job is to attach to viruses and expose specific parts of them to our immune cells, which fight the virus in response. The genetic variations on the genes directly affect the structure of the proteins, and finally impact their ability to present the virus properly and trigger an immune response.

Interestingly, the study also found that the same genetic variant can affect immune responses differently depending on the virus. For example, a variation can decrease immunity against influenza A but increase it for Epstein-Barr virus. The same variants are already known to also play a role in autoimmune diseases that could be modulated by viruses.

But the scientists emphasize that while the study shows correlations, it does not imply causation, which has to be investigated in the future. Nonetheless, the work opens a novel way for exploring, understanding and perhaps even boosting immunity with treatments guided by genomic information.
-end-
This work was funded by the Max Planck Society and the Swiss National Science Foundation.

Reference

Hammer C, Begemann M, McLaren PJ, Bartha I, Michel A, Klose B, Schmitt C, Waterboer T, Pawlita M, Schulz TF, Ehrenreich H, Fellay J. Amino Acid Variation in HLA Class II Proteins Is a Major Determinant of Humoral Response to Common Viruses. American Journal of Human Genetics 05 November 2015. DOI: 10.1016/j.ajhg.2015.09.008

Ecole Polytechnique Fédérale de Lausanne

Related Immune Response Articles:

Early immune response may improve cancer immunotherapies
Researchers report a new mechanism for detecting foreign material during early immune responses.
Researchers decode the immune response to Ebola vaccine
The vaccine rVSV-EBOV is currently used in the fight against Ebola virus.
Immune response depends on mathematics of narrow escapes
The way immune cells pick friends from foes can be described by a classic maths puzzle known as the 'narrow escape problem'.
Signature of an ineffective immune response to cancer revealed
Our immune system is programmed to destroy cancer cells. Sometimes it has trouble slowing disease progression because it doesn't act quickly or strongly enough.
Putting the break on our immune system's response
Researchers have discovered how a tiny molecule known as miR-132 acts as a 'handbrake' on our immune system -- helping us fight infection.
Having stressed out ancestors improves immune response to stress
Having ancestors who were frequently exposed to stressors can improve one's own immune response to stressors, according to Penn State researchers.
Researchers discovered new immune response regulators
The research groups of Academy Professor Riitta Lahesmaa and Research Director Laura Elo from Turku Centre for Biotechnology have discovered new proteins that regulate T cells in the human immune system.
Blueprint for plant immune response found
Washington State University researchers have discovered the way plants respond to disease-causing organisms, and how they protect themselves, leading the way to potential breakthroughs in breeding resistance to diseases or pests.
Immune response mechanism described for fate determination of T cells
In a paper published in the journal Science, University of Alabama at Birmingham researchers and colleagues at four other United States institutions have detailed a mechanism that sets the stage for the fate decision that gives rise to two major subsets of effector cells: T follicular helper cells and non-T follicular helper cells, known as Tfh and non-Tfh cells.
Retinoic acid may improve immune response against melanoma
University of Colorado Cancer Center clinical trial results describe a promising strategy to remove one of melanoma's most powerful defenses: By adding retinoic acid to standard-of-care treatment, researchers were able to turn off myeloid-derived suppressor cells (MDSCs) that turn off the immune system, leading to more immune system activity directed at melanoma.
More Immune Response News and Immune Response Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

In & Out Of Love
We think of love as a mysterious, unknowable force. Something that happens to us. But what if we could control it? This hour, TED speakers on whether we can decide to fall in — and out of — love. Guests include writer Mandy Len Catron, biological anthropologist Helen Fisher, musician Dessa, One Love CEO Katie Hood, and psychologist Guy Winch.
Now Playing: Science for the People

#543 Give a Nerd a Gift
Yup, you guessed it... it's Science for the People's annual holiday episode that helps you figure out what sciency books and gifts to get that special nerd on your list. Or maybe you're looking to build up your reading list for the holiday break and a geeky Christmas sweater to wear to an upcoming party. Returning are pop-science power-readers John Dupuis and Joanne Manaster to dish on the best science books they read this past year. And Rachelle Saunders and Bethany Brookshire squee in delight over some truly delightful science-themed non-book objects for those whose bookshelves are already full. Since...
Now Playing: Radiolab

An Announcement from Radiolab